DE69939532D1 - Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung - Google Patents

Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung

Info

Publication number: DE69939532D1
Authority: DE; Germany
Prior art keywords: aminobutteric; gamma; production; acid derivatives; solid medicaments
Prior art date: 1998-05-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69939532T

Other languages

English (en)

Inventor

Akira Aomatsu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Warner Lambert Co LLC

Original Assignee

Warner Lambert Co LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-15

Filing date

1999-05-10

Publication date

2008-10-23

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15097314&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69939532(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-05-10 Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC

1999-05-10 Priority claimed from PCT/US1999/010186 external-priority patent/WO1999059572A1/en

2008-10-23 Application granted granted Critical

2008-10-23 Publication of DE69939532D1 publication Critical patent/DE69939532D1/de

2019-05-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Arrangement Of Transmissions (AREA)
Body Structure For Vehicles (AREA)

DE69939532T 1998-05-15 1999-05-10 Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung Expired - Lifetime DE69939532D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP13312298A JP3761324B2 (ja)	1998-05-15	1998-05-15	乗用田植機
PCT/US1999/010186 WO1999059572A1 (en)	1998-05-15	1999-05-10	Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same

Publications (1)

Publication Number	Publication Date
DE69939532D1 true DE69939532D1 (de)	2008-10-23

Family

ID=15097314

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69939532T Expired - Lifetime DE69939532D1 (de)	1998-05-15	1999-05-10	Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung

Country Status (16)

Country	Link
JP (1)	JP3761324B2 (de)
CN (1)	CN1171587C (de)
AT (1)	ATE407668T1 (de)
CA (1)	CA2325045C (de)
CY (1)	CY1108488T1 (de)
DE (1)	DE69939532D1 (de)
DK (1)	DK1077691T3 (de)
EA (1)	EA006553B1 (de)
EE (1)	EE05530B1 (de)
EG (1)	EG26287A (de)
ES (1)	ES2312208T3 (de)
GE (1)	GEP20032987B (de)
IL (2)	IL139202A0 (de)
NZ (1)	NZ507162A (de)
PT (1)	PT1077691E (de)
UA (1)	UA76398C2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4904636B2 (ja) *	2001-05-29	2012-03-28	井関農機株式会社	トラクタフレーム
JP5047022B2 (ja) *	2008-03-24	2012-10-10	ヤンマー株式会社	上下分割式のエンジン収納用パッケージの結合構造
WO2013008182A1 (en) *	2011-07-10	2013-01-17	Mahesh Kandula	Prodrugs of gaba analogs
WO2014037832A2 (en)	2012-09-06	2014-03-13	Mahesh Kandula	Compositions and methods for the treatment of epilepsy and neurological diseases
WO2013168019A1 (en) *	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of neuropathic pain
EP2847158A4 (de)	2012-05-07	2015-12-30	Cellix Bio Private Ltd	Zusammensetzungen und verfahren zur behandlung neuromuskulärer erkrankungen und neurodegenerativer erkrankungen
SG11201407300VA (en)	2012-05-07	2014-12-30	Cellix Bio Private Ltd	Compositions and methods for the treatment of neurological disorders
WO2013167990A1 (en)	2012-05-07	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of depression
US9309233B2 (en)	2012-05-08	2016-04-12	Cellix Bio Private Limited	Compositions and methods for the treatment of blood clotting disorders
WO2013167993A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of neurological degenerative disorders
US9522884B2 (en)	2012-05-08	2016-12-20	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic disorders
WO2013167992A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of inflammatory disorders
WO2013168023A1 (en)	2012-05-08	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of parkinson's disease
WO2013168001A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of moderate to severe pain
US9394288B2 (en)	2012-05-10	2016-07-19	Cellix Bio Private Limited	Compositions and methods for the treatment of asthma and allergy
US9315461B2 (en)	2012-05-10	2016-04-19	Cellix Bio Private Limited	Compositions and methods for the treatment of neurologic diseases
US20150087674A1 (en) *	2012-05-10	2015-03-26	Mahesh Kandula	Compositions and methods for the treatment of severe pain
WO2013167997A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of metabolic syndrome
WO2013168033A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for treatment of neurologic diseases
WO2013168000A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of severe pain
WO2013168011A1 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of chronic pain
WO2013168004A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of fibromyalgia pain
US9233161B2 (en)	2012-05-10	2016-01-12	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological conditions
WO2013168005A2 (en)	2012-05-10	2013-11-14	Mahesh Kandula	Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US9403857B2 (en)	2012-05-10	2016-08-02	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
US9499527B2 (en)	2012-05-10	2016-11-22	Cellix Bio Private Limited	Compositions and methods for the treatment of familial amyloid polyneuropathy
US9242939B2 (en)	2012-05-10	2016-01-26	Cellix Bio Private Limited	Compositions and methods for the treatment of respiratory disorders
CA2873098A1 (en)	2012-05-23	2013-11-28	Cellixbio Private Limited	Compositions and methods for the treatment of multiple sclerosis
SG11201407319YA (en)	2012-05-23	2014-12-30	Cellix Bio Private Ltd	Compositions and methods for treatment of inflammatory bowel disease
WO2013175347A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of respiratory disorders
WO2013175344A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
SG11201407326XA (en)	2012-05-23	2014-12-30	Cellix Bio Private Ltd	Compositions and methods for treatment of mucositis
WO2013175376A2 (en)	2012-05-23	2013-11-28	Mahesh Kandula	Compositions and methods for the treatment of local pain
US9108942B1 (en)	2014-11-05	2015-08-18	Mahesh Kandula	Compositions and methods for the treatment of moderate to severe pain
WO2014020480A2 (en)	2012-08-03	2014-02-06	Mahesh Kandula	Compositions and methods for the treatment migraine and neurologic diseases
WO2014037833A2 (en)	2012-09-06	2014-03-13	Mahesh Kandula	Compositions and methods for the treatment inflammation and lipid disorders
CA2873029A1 (en)	2012-09-08	2014-03-13	Cellixbio Private Limited	Compositions and methods for the treatment of inflammation and lipid disorders
US9333187B1 (en)	2013-05-15	2016-05-10	Cellix Bio Private Limited	Compositions and methods for the treatment of inflammatory bowel disease
SG11201509782TA (en)	2013-06-04	2015-12-30	Cellix Bio Private Ltd	Compositions and methods for the treatment of diabetes and pre-diabetes
US9096537B1 (en)	2014-12-31	2015-08-04	Mahesh Kandula	Compositions and methods for the treatment of mucositis
CA2976314C (en)	2014-09-26	2021-02-23	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy and neurological disorders
CA2967908C (en)	2014-09-29	2020-11-17	Mahesh Kandula	Compositions and methods for the treatment of multiple sclerosis
CN104352476A (zh) *	2014-10-21	2015-02-18	齐宏	一种加巴喷丁胶囊及其制备方法
JP6564868B2 (ja)	2014-10-27	2019-08-21	セリックスバイオプライヴェートリミテッドＣｅｌｌｉｘＢｉｏＰｒｉｖａｔｅＬｉｍｉｔｅｄ	多発性硬化症の治療のための、フマル酸モノメチルエステルとピペラジン又はエチレンジアミンとの３つの成分の塩
US10208014B2 (en)	2014-11-05	2019-02-19	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological disorders
US9321716B1 (en)	2014-11-05	2016-04-26	Cellix Bio Private Limited	Compositions and methods for the treatment of metabolic syndrome
US9150557B1 (en)	2014-11-05	2015-10-06	Cellix Bio Private Limited	Compositions and methods for the treatment of hyperglycemia
US9175008B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Prodrugs of anti-platelet agents
US9173877B1 (en)	2014-11-05	2015-11-03	Cellix Bio Private Limited	Compositions and methods for the treatment of local pain
US9284287B1 (en)	2014-11-05	2016-03-15	Cellix Bio Private Limited	Compositions and methods for the suppression of carbonic anhydrase activity
US9290486B1 (en)	2014-11-05	2016-03-22	Cellix Bio Private Limited	Compositions and methods for the treatment of epilepsy
US9932294B2 (en)	2014-12-01	2018-04-03	Cellix Bio Private Limited	Compositions and methods for the treatment of multiple sclerosis
US9206111B1 (en)	2014-12-17	2015-12-08	Cellix Bio Private Limited	Compositions and methods for the treatment of neurological diseases
CN110845355A (zh)	2015-01-06	2020-02-28	塞尔利克斯生物私人有限公司	用于治疗炎症和疼痛的组合物和方法

1998
- 1998-05-15 JP JP13312298A patent/JP3761324B2/ja not_active Expired - Fee Related
1999
- 1999-05-10 GE GEAP19995678A patent/GEP20032987B/en unknown
- 1999-05-10 CN CNB998059781A patent/CN1171587C/zh not_active Expired - Fee Related
- 1999-05-10 NZ NZ507162A patent/NZ507162A/en not_active IP Right Cessation
- 1999-05-10 DK DK99924164T patent/DK1077691T3/da active
- 1999-05-10 ES ES99924164T patent/ES2312208T3/es not_active Expired - Lifetime
- 1999-05-10 IL IL13920299A patent/IL139202A0/xx unknown
- 1999-05-10 EA EA200001154A patent/EA006553B1/ru not_active IP Right Cessation
- 1999-05-10 AT AT99924164T patent/ATE407668T1/de active
- 1999-05-10 PT PT99924164T patent/PT1077691E/pt unknown
- 1999-05-10 CA CA002325045A patent/CA2325045C/en not_active Expired - Lifetime
- 1999-05-10 EE EEP200000671A patent/EE05530B1/xx unknown
- 1999-05-10 DE DE69939532T patent/DE69939532D1/de not_active Expired - Lifetime
- 1999-05-13 EG EG1999050553A patent/EG26287A/en active
- 1999-10-05 UA UA2000127205A patent/UA76398C2/uk unknown
2000
- 2000-10-23 IL IL139202A patent/IL139202A/en not_active IP Right Cessation
2008
- 2008-11-06 CY CY20081101268T patent/CY1108488T1/el unknown

Also Published As

Publication number	Publication date
EE200000671A (et)	2002-04-15
JPH11318133A (ja)	1999-11-24
EA006553B1 (ru)	2006-02-24
CY1108488T1 (el)	2014-04-09
PT1077691E (pt)	2008-11-04
CA2325045C (en)	2005-05-03
IL139202A (en)	2014-12-31
EA200001154A1 (ru)	2001-06-25
CA2325045A1 (en)	1999-11-25
CN1171587C (zh)	2004-10-20
EG26287A (en)	2013-06-12
ATE407668T1 (de)	2008-09-15
NZ507162A (en)	2003-11-28
DK1077691T3 (da)	2008-10-27
JP3761324B2 (ja)	2006-03-29
UA76398C2 (en)	2006-08-15
GEP20032987B (en)	2003-06-25
IL139202A0 (en)	2001-11-25
EE05530B1 (et)	2012-04-16
CN1300213A (zh)	2001-06-20
ES2312208T3 (es)	2009-02-16

Publication	Publication Date	Title
DE69939532D1 (de)	2008-10-23	Gamma-aminobuttersäurederivate enthaltende, feste arzneimittel und verfahren zu ihrer herstellung
MA23170A1 (fr)	1994-12-31	Procede de preparation d'un nouveau compose .
GEP20002298B (en)	2000-11-25	Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
UA44254C2 (uk)	2002-02-15	Похідні 4-(заміщеного феніламіно)хіназоліну, спосіб їх одержання, спосіб лікування і фармацевтична композиція
ATE130758T1 (de)	1995-12-15	Arzneimittel zur intranasalen verabreichung, die ketorolac r enthalten.
BR9510168A (pt)	1997-10-14	Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
DE59109082D1 (de)	1999-02-11	Mono-N-substituierte 1,4,7,10-Tetraazacyclododecan-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
AU2003225617A1 (en)	2003-09-16	Thiadiazolylpiperazine derivatives useful for treating or preventing pain
MY115662A (en)	2003-08-30	Novel compounds with analgesic effect
RU94046044A (ru)	1996-10-10	Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения
GEP20022654B (en)	2002-03-25	Indazole Amide Compounds As Serotoninergic Agents
ATE84045T1 (de)	1993-01-15	Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
SE0300908D0 (sv)	2003-03-31	Azaindole derivatives, preparations thereof, uses thereof and compositions containing them
JPH0256413A (ja)	1990-02-26	歯の汚れを防止する組成物
RU98103388A (ru)	1999-11-10	(r)-5-бром-n-(1-этил-4-метилгексагидро-1н-1,4-диазепин-6-ил)-2-метокси-6-м етиламино-3-пиридинкарбоксамид, способ его получения и фармацевтическая композиция, содержащая указанное соединение
HUT70531A (en)	1995-10-30	Arylmorpholine derivatives, pharmaceutical compositions containing them as active agent and process for preparing them
DE69837045D1 (de)	2007-03-22	Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren, ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
GEP20032924B (en)	2003-03-25	Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
CA2202904A1 (en)	1996-04-25	Pharmaceutical composition for prophylaxis and treatment of type i allergic diseases
CA2038025A1 (en)	1991-09-15	Optically active alkylenedioxybenzene derivatives and their use in therapy
DE69512419D1 (de)	1999-10-28	IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
CA2133186A1 (en)	1995-03-29	3- or 4-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
DE69910738D1 (de)	2003-10-02	Fungizide zusammensetzung enthaltend ein n-benzoyl-n'-phenyl-harnstoff derivat
IT1273455B (it)	1997-07-08	Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ATE63114T1 (de)	1991-05-15	Piperazinderivate, verfahren zu ihrer herstellung und diese als wirkstoffe enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date	Code	Title	Description
2009-10-01	8364	No opposition during term of opposition